武田薬品工業 投資有価証券評価損、Reversal Of Reserve For Advanced Depreciation Of Noncurrent Assets、Total Changes Of Items During The Period Reserve For Promotion Of Exports他2件
投資有価証券評価損、Reversal Of Reserve For Advanced Depreciation Of Noncurrent Assets、Total Changes Of Items During The Period Reserve For Promotion Of Exports他2件 【期間】 年度 投資有価証券評価損 Reversal Of Reserve For Advanced Depreciation Of Noncurrent Assets Total Changes Of Items During The Period Reserve For Promotion Of Exports 合計 金融費用(IFRS) 2018/03 - - - 1.19兆 319億 2019/03 - - - 1.95兆 +64.1% 833億 +160.9% 2020/03 - - - 2.08兆 +6.6% 1650億 +98.1% 2021/03 - - - 2.19兆 +5.2% 2486億 +50.7% 2022/03 - - - 2.45兆 +11.9% 1666億 -33% 2023/03 - - - 2.7兆 +10% 1697億 +1.9% 2024/03 - - - - 2199億 +29.6%
勘定科目を追加して比較 損益計算書 貸借対照表 キャッシュ・フロー計算書 株主資本等変動計算書 包括利益計算書 各セグメントの情報